| Literature DB >> 25209168 |
Ralf Brand1, Wanja Wolff, Detlef Thieme.
Abstract
BACKGROUND: Knowing and, if necessary, altering competitive athletes' real attitudes towards the use of banned performance-enhancing substances is an important goal of worldwide doping prevention efforts. However athletes will not always be willing to reporting their real opinions. Reaction time-based attitude tests help conceal the ultimate goal of measurement from the participant and impede strategic answering. This study investigated how well a reaction time-based attitude test discriminated between athletes who were doping and those who were not. We investigated whether athletes whose urine samples were positive for at least one banned substance (dopers) evaluated doping more favorably than clean athletes (non-dopers).Entities:
Mesh:
Substances:
Year: 2014 PMID: 25209168 PMCID: PMC4163696 DOI: 10.1186/1747-597X-9-36
Source DB: PubMed Journal: Subst Abuse Treat Prev Policy ISSN: 1747-597X
Prohibited substances in urine samples of bodybuilders (n = number of participants)
| Methandienone (n = 5) | hCG (n = 1) | Tamoxifene (n = 6) | Methylhexanamine (n = 2) | cTHC (n = 2) |
| Boldenone (n = 13) | | Anastrozol (n = 2) | Amphetamine (n = 1) | |
| Drostanolone (n = 4) | | | Ephedrine (n = 1) | |
| Methasterone (n = 1) | | | MDMA (n = 1) | |
| Metenolone (n = 1) | | | | |
| Nandrolone (n = 11) | | | | |
| Oxymetholone (n = 1) | | | | |
| Stanozolol (n = 4) | | | | |
| Testosterone (n = 20) | | | | |
| Trenbolone (n = 6) | | | | |
| Clenbuterol (n = 1) |
Substances are grouped (S1 to S8) according to the WADA Prohibited List 2013.15 hCG (human chorionic gonadotropin) induces the endogenous biosynthesis of testosterone, MDMA (3,4-methylenedioxyamphetamine) is the stimulating entactogen marketed as ecstasy, and cTHC (11-nor-9-carboxy-THC) is the urinary marker of THC-administration.
Figure 1Results from the doping BIAT attitude measurement. Bars show mean reaction times (±1 standard deviation) in groups of bodybuilders whose urine samples either contained (dopers; n = 26) or did not contain (non-dopers; n = 35) forbidden substances according to the WADA prohibited list 2013. Block A refers to the BIAT’s part, in which the target concept doping and the evaluative concept like are mapped on the same response key (and block B respectively).
Figure 2Results of ROC analysis (receiver operating characteristic). The ROC curve (black) describes the BIAT’s performance in discriminating dopers from non-dopers. The ROC graph depicts relative tradeoffs between true positives (test sensitivity) and false positives (test specificity) as a function of each obtained BIAT score. The farther the AUC (Area Under the Curve = 0.722 ± CI95%) deviates from the diagonal (grey) representing chance level (AUC = 0.50), the better the BIAT’s performance is in terms of maximizing true positive and true negative cases. At the proposed BIAT cut-off score (-0.57), specificity (54.3%) and sensitivity (84.6%) are maximized.
True hits and false alarms (number of participants) produced by the doping BIAT cut-off -score, proposed to discriminate test participants (here: bodybuilders) with a rather negative ( ≤ -0.57) or a rather positive ( > -0.57) doping attitude
| Biochemical test: presence of doping substance in urine sample | Doper | 4 | 22 |
| Non-doper | 19 | 16 | |
Figure 3Application of proposed reference thresholds on doping BIAT -scores. Dots represent all bodybuilders’ (dopers and non-dopers) individual D-scores. Lower and upper limits of the grey box represent the range of the 95% confidence interval (-0.72, -0.46) around the cut-off D-score (horizontal line at -0.57) as proposed by the ROC analysis.